Astria Therapeutics Statistics

Total Valuation

ATXS has a market cap or net worth of $539.51 million. The enterprise value is $200.87 million.

Market Cap	539.51M
Enterprise Value	200.87M

Important Dates

The last earnings date was Wednesday, November 13, 2024, after market close.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

ATXS has 56.43 million shares outstanding. The number of shares has increased by 97.76% in one year.

Current Share Class	56.43M
Shares Outstanding	56.43M
Shares Change (YoY)	+97.76%
Shares Change (QoQ)	+2.36%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	55.93%
Float	30.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.19
P/TBV Ratio	2.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 22.38, with a Debt / Equity ratio of 0.02.

Current Ratio	22.38
Quick Ratio	21.90
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -38.03% and return on invested capital (ROIC) is -23.71%.

Return on Equity (ROE)	-38.03%
Return on Assets (ROA)	-22.72%
Return on Capital (ROIC)	-23.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.70M
Employee Count	59
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.94% in the last 52 weeks. The beta is 0.67, so ATXS's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+54.94%
50-Day Moving Average	10.68
200-Day Moving Average	10.87
Relative Strength Index (RSI)	42.48
Average Volume (20 Days)	380,921

Short Selling Information

The latest short interest is 3.15 million, so 5.57% of the outstanding shares have been sold short.

Short Interest	3.15M
Short Previous Month	2.90M
Short % of Shares Out	5.57%
Short % of Float	10.28%
Short Ratio (days to cover)	12.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-100.97M
Pretax Income	-81.63M
Net Income	-100.04M
EBITDA	n/a
EBIT	-100.97M
Earnings Per Share (EPS)	-$1.97

Full Income Statement

Balance Sheet

The company has $344.28 million in cash and $5.64 million in debt, giving a net cash position of $338.65 million or $6.00 per share.

Cash & Cash Equivalents	344.28M
Total Debt	5.64M
Net Cash	338.65M
Net Cash Per Share	$6.00
Equity (Book Value)	341.65M
Book Value Per Share	4.36
Working Capital	336.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$94.09 million and capital expenditures -$341,000, giving a free cash flow of -$94.43 million.

Operating Cash Flow	-94.09M
Capital Expenditures	-341,000
Free Cash Flow	-94.43M
FCF Per Share	-$1.67

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATXS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-97.76%
Shareholder Yield	-97.76%
Earnings Yield	-18.54%
FCF Yield	-17.50%

Analyst Forecast

The average price target for ATXS is $28.00, which is 192.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.00
Price Target Difference	192.89%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-36.88%

Stock Forecasts

Stock Splits

The last stock split was on August 20, 2021. It was a reverse split with a ratio of 0.1666667:1.

Last Split Date	Aug 20, 2021
Split Type	Reverse
Split Ratio	0.1666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2